CGON

79.4702.97%
SE

Susan E. Graf

Independent Director

Ms. Susan E. Graf, R.PH., MBA is Senior Advisor & EIR of Boston of Locust Walk Partners, LLC. She is an Independent Director of Aardvark Therapeutics, Inc. since November 14, 2024. She serves as Independent Director at CG Oncology, Inc. since November 2023. From April 2021 to March 2024, she chaired the board of directors of Finch Therapeutics, Inc. She serves as Director at kaleo, Inc. Ms. Graf is a Senior Advisor and Entrepreneur in Residence at Locust Walk Partners, LLC. She has been Director of Kaléo, Inc. She had been an Independent Director at Finch Therapeutics Group, Inc. since April 23, 2021 until 2024 and had been its Independent Chairman since April 25, 2022 until 2024. Ms. Graf previously served as Chief Executive Officer of Akamara Therapeutics from August 2019 to May 2021. She was Chief Business Officer of Epizyme, Inc. since April 25, 2016 until September 30, 2018 and Principal Financial Officer from August 2017 to September 2018. She served as Vice President of Corporate Development & Strategy at NPS Pharmaceuticals, Inc. from May 2013 to 2015. She served as Director of Global Business Development, Director of U.S. marketing and Global Head of Strategic Evaluation. Prior to NPS Pharma, she spent many years at Roche in a number of leadership and executive positions in business development, commercial assessment, due diligence, mergers & acquisitions, marketing, market research, sales and manufacturing. She was recognized as a Healthcare Businesswomen’s Association Rising Star in 2011 and has been named to Purdue University’s ’40 Under 40’ list. Ms. Graf is a licensed pharmacist and received her B.Pharm. from Purdue University and her Master of Business Administration degree from the Leonard N. Stern School of Business at New York University.

Positions